Research aimed at improving both mood and weight (RAINBOW) in primary care: A type 1 hybrid design randomized controlled trial

Contemporary Clinical Trials

Volumn 43, Issue , 2015, Pages 260-278

  Ma, Jun ^a,b   Yank, Veronica ^b   Lv, Nan ^a   Goldhaber Fiebert, Jeremy D ^c   Lewis, Megan A ^d   Kramer, M Kaye ^e   Snowden, Mark B ^f   Rosas, Lisa G ^a,b   Xiao, Lan ^a   Blonstein, Andrea C ^a  

^a PALO ALTO MEDICAL FOUNDATION RESEARCH INSTITUTE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY   (United States)

^d RTI INTERNATIONAL   (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Depression; Lifestyle change; Obesity; Problem solving therapy; Randomized controlled trial; Standard behavioral treatment

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; ANXIETY; ARTICLE; BEHAVIOR CHANGE; BEHAVIOR THERAPY; BODY WEIGHT MANAGEMENT; CLINICAL RESEARCH; COMORBIDITY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DIETARY INTAKE; DISABILITY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEALTH CARE; HEALTH CARE DELIVERY; HEALTH CARE UTILIZATION; HUMAN; INFORMATION PROCESSING; INTERNET; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MEDICATION THERAPY MANAGEMENT; MOBILE APPLICATION; MOOD; OBESITY; OUTCOME ASSESSMENT; PATIENT SAFETY; PEDOMETER; PHYSICAL ACTIVITY; PRIMARY MEDICAL CARE; PROBLEM SOLVING; QUALITY CONTROL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SOCIAL COGNITIVE THEORY; TELECONSULTATION; AFFECT; AGE; ANCESTRY GROUP; BODY MASS; BODY WEIGHT; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DEPRESSIVE DISORDER; ECONOMICS; METHODOLOGY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; ORGANIZATION AND MANAGEMENT; PRIMARY HEALTH CARE; PROCEDURES; SEX DIFFERENCE; SOCIOECONOMICS;

AFFECT; AGE FACTORS; ANTIDEPRESSIVE AGENTS; BEHAVIOR THERAPY; BODY MASS INDEX; BODY WEIGHT; COMBINED MODALITY THERAPY; CONTINENTAL POPULATION GROUPS; COST-BENEFIT ANALYSIS; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; OBESITY; PRIMARY HEALTH CARE; RESEARCH DESIGN; SEX FACTORS; SOCIOECONOMIC FACTORS;

EID: 84936749989     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2015.06.010     Document Type: Article

References (98)

1. Faith M.S., Butryn M., Wadden T.A., Fabricatore A., Nguyen A.M., Heymsfield S.B. Evidence for prospective associations among depression and obesity in population-based studies. Obes. Rev. 2011, 12(5):e438-e453.
2. Flegal K.M., Carroll M.D., Kit B.K., Ogden C.L. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012, 307(5):491-497.
3. Nguyen N.T., Nguyen X.M., Lane J., Wang P. Relationship between obesity and diabetes in a US adult population: findings from the National Health and Nutrition Examination Survey, 1999-2006. Obes. Surg. 2011, 21(3):351-355.
4. Jokinen E. Obesity and cardiovascular disease. Minerva Pediatr. 2015, 67(1):25-32.
5. Chapman D.P., Perry G.S., Strine T.W. The vital link between chronic disease and depressive disorders. Prev. Chronic Dis. 2005, 2(1):1-10.
6. World Health Organization The World Health Report 2002: Reducing Risks, Promoting Healthy Life 2002, World Health Organization, Geneva, Switzerland.
7. Summary: The Global Burden of Disease 1996, Harvard School of Public Health, Boston, MA. J.L. Murray, A.D. Lopez (Eds.).
8. Inter-university Consortium for Political and Social Research National Comorbidity Survey Replication (NCS-R) Lifetime and Twelve-month Prevalence estimates (Accessed June 16, 2008). http://www.hcp.med.harvard.edu/ncs/index.php.
9. Gonzalez H.M., Tarraf W., Whitfield K.E., Vega W.A. The epidemiology of major depression and ethnicity in the United States. J. Psychiatr. Res. 2010, 44(15):1043-1051.
10. Blanco C., Okuda M., Markowitz J.C., Liu S.M., Grant B.F., Hasin D.S. The epidemiology of chronic major depressive disorder and dysthymic disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J. Clin. Psychiatry 2010, 71(12):1645-1656.
11. Preiss K., Brennan L., Clarke D. A systematic review of variables associated with the relationship between obesity and depression. Obes. Rev. 2013, 14(11):906-918.
12. Bjerkeset O., Romundstad P., Evans J., Gunnell D. Association of adult body mass index and height with anxiety, depression, and suicide in the general population: the HUNT study. Am. J. Epidemiol. 2008, 167(2):193-202.
13. Herva A., Laitinen J., Miettunen J., et al. Obesity and depression: results from the longitudinal Northern Finland 1966 Birth Cohort Study. Int. J. Obes. (Lond.) 2006, 30(3):520-527.
14. Blaine B. Does depression cause obesity? A meta-analysis of longitudinal studies of depression and weight control. J. Health Psychol. 2008, 13(8):1190-1197.
15. Ladwig K.H., Marten-Mittag B., Lowel H., Doring A., Wichmann H.E. Synergistic effects of depressed mood and obesity on long-term cardiovascular risks in 1510 obese men and women: results from the MONICA-KORA Augsburg Cohort Study 1984-1998. Int. J. Obes. (Lond.) 2006, 30(9):1408-1414.
16. Werrij M.Q., Mulkens S., Hospers H.J., Jansen A. Overweight and obesity: the significance of a depressed mood. Patient Educ. Couns. 2006, 62(1):126-131.
17. Katon W.J. Epidemiology and treatment of depression in patients with chronic medical illness. Dialogues Clin. Neurosci. 2011, 13(1):7-23.
18. Faulconbridge L.F., Wadden T.A., Rubin R.R., et al. One-year changes in symptoms of depression and weight in overweight/obese individuals with type 2 diabetes in the Look AHEAD study. Obesity (Silver Spring) 2012, 20(4):783-793.
19. Rubin R.R., Wadden T.A., Bahnson J.L., et al. Impact of intensive lifestyle intervention on depression and health-related quality of life in type 2 diabetes: the Look AHEAD Trial. Diabetes Care 2014, 37(6):1544-1553.
20. Linde J.A., Simon G.E., Ludman E.J., et al. A randomized controlled trial of behavioral weight loss treatment versus combined weight loss/depression treatment among women with comorbid obesity and depression. Ann. Behav. Med. 2011, 41(1):119-130.
21. Pagoto S., Schneider K.L., Whited M.C., et al. Randomized controlled trial of behavioral treatment for comorbid obesity and depression in women: the Be Active Trial. Int. J. Obes. (Lond.) 2013, 37(11):1427-1434.
22. Curran G.M., Bauer M., Mittman B., Pyne J.M., Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med. Care 2012, 50(3):217-226.
23. Xiao L., Huang Q., Yank V., Ma J. An easily accessed web-based minimization random allocation system for clinical trials. JMIR 2013, 15(7):e139.
24. Ma J., Yank V., Xiao L., et al. Translating the Diabetes Prevention Program lifestyle intervention for weight loss into primary care: a randomized trial. JAMA Intern. Med. 2013, 173(2):113-121.
25. Ma J., Strub P., Lavori P.W., et al. DASH for asthma: a pilot study of the DASH diet in not-well-controlled adult asthma. Contemp. Clin. Trials 2013, 35(2):55-67.
26. Pocock S.J. Clinical Trials, A Practical Approach 1991, 84-86. John Wiley and Sons, Chichester.
27. Pocock S.J., Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 1975, 31(1):103-115.
28. Efron B. Forcing sequential experiment to be balanced. Biometrika 1971, 58:403-417.
29. Lin E.H., Von Korff M., Ciechanowski P., et al. Treatment adjustment and medication adherence for complex patients with diabetes, heart disease, and depression: a randomized controlled trial. Ann. Fam. Med. 2012, 10(1):6-14.
30. Ma J., King A.C., Wilson S.R., Xiao L., Stafford R.S. Evaluation of lifestyle interventions to treat elevated cardiometabolic risk in primary care (E-LITE): a randomized controlled trial. BMC Fam. Pract. 2009, 10:71.
31. Kramer M.K., Kriska A.M., Venditti E.M., et al. Translating the Diabetes Prevention Program: a comprehensive model for prevention training and program delivery. Am. J. Prev. Med. 2009, 37(6):505-511.
32. Ciechanowski P., Wagner E., Schmaling K., et al. Community-integrated home-based depression treatment in older adults: a randomized controlled trial. JAMA 2004, 291(13):1569-1577.
33. Ciechanowski P., Chaytor N., Miller J., et al. PEARLS depression treatment for individuals with epilepsy: a randomized controlled trial. Epilepsy Behav. 2010, 19(3):225-231.
34. University of Pittsburge Diabetes Prevention Support Center GLB Lifestyle Coach Training (Accessed March 13, 2015). http://www.diabetesprevention.pitt.edu/index.php/training/glb-lifestyle-coach-training/.
35. University of Washington PEARLS Program (Accessed June 28, 2012). http://www.pearlsprogram.org/Training.aspx.
36. Kramer M.K., Kriska A.M., Venditti E.M., et al. A novel approach to diabetes prevention: evaluation of the Group Lifestyle Balance program delivered via DVD. Diabetes Res. Clin. Pract. 2010, 90(3):e60-e63.
37. Chaytor N., Ciechanowski P., Miller J.W., et al. Long-term outcomes from the PEARLS randomized trial for the treatment of depression in patients with epilepsy. Epilepsy Behav. 2011, 20(3):545-549.
38. Katon W.J., Lin E.H., Von Korff M., et al. Collaborative care for patients with depression and chronic illnesses. N. Engl. J. Med. 2010, 363(27):2611-2620.
39. Bandura A. Social foundations of thought and action: a social cognitive theory 1986, Prentice Hall, Englewood Cliffs, N.J.
40. Ma J., Strub P., Camargo C.A., et al. The Breathe Easier through Weight Loss Lifestyle (BE WELL) Intervention: a randomized controlled trial. BMC Pulm. Med. 2010, 10:16.
41. Measures from the PhenX Toolkit version February 4 2011, Ver 4.2 (PhenX (consensus measures of Phenotypes and eXposures) is supported by NHGRI award No. U01 HG004597. Accessed January 15, 2015). http://www.phenxtoolkit.org.
42. Goldberg D.P., Rickels K., Downing R., Hesbacher P. A comparison of two psychiatric screening tests. Br. J. Psychiatry 1976, 129:61-67.
43. Glass R.M., Allan A.T., Uhlenhuth E.H., Kimball C.P., Borinstein D.I. Psychiatric screening in a medical clinic. An evaluation of a self-report inventory. Arch. Gen. Psychiatry 1978, 35(10):1189-1195.
44. Karlsson J., Taft C., Sjostrom L., Torgerson J.S., Sullivan M. Psychosocial functioning in the obese before and after weight reduction: construct validity and responsiveness of the Obesity-related Problems scale. Int. J. Obes. Relat. Metab. Disord. 2003, 27(5):617-630.
45. Spitzer R.L., Kroenke K., Williams J.B., Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch. Intern. Med. 2006, 166(10):1092-1097.
46. Sheehan D.V., Lecrubier Y., Sheehan K.H., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 1998, 59(Suppl. 20):22-33. (quiz 34-57).
47. Sheehan K.H., Sheehan D.V. Assessing treatment effects in clinical trials with the discan metric of the Sheehan Disability Scale. Int. Clin. Psychopharmacol. 2008, 23(2):70-83.
48. Ware J.E., Kosinski M., Dewey J.E., Gandek B. How to Score and Interpret Single-Item Health Status Measures: A Manual for Users of the SF-8 Health Survey 2001, QualityMetric Incorporated, Lincoln RI.
49. Badia X., Schiaffino A., Alonso J., Herdman M. Using the EuroQoI 5-D in the Catalan general population: feasibility and construct validity. Qual. Life Res. 1998, 7(4):311-322.
50. Schafer G.L., Songer T.J., Kramer M.K., Miller R.G., Vanderwood K.K., Kriska A. Do food costs increase for participants in a diabetes prevention program?. Paper Presented at: American Diabetes Association 73rd Scientific Sessions 2013, (Chicago, IL).
51. Hernan W.H., Brandle M., Zhang P., et al. Costs associated with the primary prevention of type 2 diabetes mellitus in the Diabetes Prevention Program (DPP). Diabetes Care 2003, 26(1):36-47.
52. Weathers F.W., Litz B.T., Herman D.S., Huska J.A., Keane T.M. The PTSD checklist: reliability, validity, and diagnostic utility. Paper Presented at the Annual Meeting of the International Society for Traumatic Stress Studies 1993, (San Antonio, TX).
53. Moshfegh A.J., Goldman J., Lacomb R., Perloff B., Cleveland L. Research results using the new USDA automated multiple-pass method. FASEB J. 2001, 15(4):A278. (abstr).
54. Blair S.N., Haskell W.L., Ho P., et al. Assessment of habitual physical activity by a seven-day recall in a community survey and controlled experiments. Am. J. Epidemiol. 1985, 122(5):794-804.
55. D'Zurilla T.J., Chang E.C., Nottingham EJt, Faccini L. Social problem-solving deficits and hopelessness, depression, and suicidal risk in college students and psychiatric inpatients. J. Clin. Psychol. 1998, 54(8):1091-1107.
56. Yu L., Buysse D.J., Germain A., et al. Development of short forms from the PROMIS sleep disturbance and sleep-related impairment item banks. Behav. Sleep Med. 2011, 10(1):6-24.
57. Glasgow R.E., Vogt T.M., Boles S.M. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am. J. Public Health 1999, 89(9):1322-1327.
58. Kessler R.S., Purcell E.P., Glasgow R.E., Klesges L.M., Benkeser R.M., Peek C.J. What does it mean to "employ" the RE-AIM model?. Eval. Health Prof. 2013, 36(1):44-66.
59. Robin D.B. Multiple Imputation for Nonresponse in Surveys 1987, John Wiley & Sons, Inc., New York.
60. Lavori P.W., Dawson R., Shera D. A multiple imputation strategy for clinical trials with truncation of patient data. Stat. Med. 1995, 14(17):1913-1925.
61. Schafer J.L. Analysis of Incomplete Multivariate Data 1997, Chapman and Hall, New York.
62. Tang L., Duan N., Klap R., Asarnow J.R., Belin T.R. Applying permutation tests with adjustment for covariates and attrition weights to randomized trials of health-services interventions. Stat. Med. 2009, 28(1):65-74.
63. DiCiccio T.J., Efron B. Bootstrap confidence intervals. Stat. Sci. 1996, 11(3):189-228.
64. MacKinnon D.P., Fritz M.S., Williams J., Lockwood C.M. Distribution of the product confidence limits for the indirect effect: program PRODCLIN. Behav. Res. Methods 2007, 39(3):384-389.
65. Goldhaber-Fiebert J.D., Rubinfeld R.E., Bhattacharya J., Robinson T.N., Wise P.H. The utility of childhood and adolescent obesity assessment in relation to adult health. Med. Decis. Making 2013, 33(2):163-175.
66. Hall K.D., Jordan P.N. Modeling weight-loss maintenance to help prevent body weight regain. Am. J. Clin. Nutr. 2008, 88(6):1495-1503.
67. Hall K.D. Predicting metabolic adaptation, body weight change, and energy intake in humans. Am. J. Physiol. Endocrinol. Metab. 2010, 298(3):E449-E466.
68. Herman W.H., Hoerger T.J., Brandle M., et al. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann. Intern. Med. 2005, 142(5):323-332.
69. Haji Ali Afzali H., Karnon J., Gray J. A critical review of model-based economic studies of depression: modelling techniques, model structure and data sources. Pharmacoeconomics 2012, 30(6):461-482.
70. Wein L.M., Yang Y., Goldhaber-Fiebert J.D. Assessing screening policies for childhood obesity. Obesity (Silver Spring) 2012, 20(7):1437-1443.
71. Cost-effectiveness in Health and Medicine 1996, Oxford University Press, New York. M.R. Gold, J.E. Siegel, L.B. Russell, M.C. Weinstein (Eds.).
72. Kraemer H.C., Kupfer D.J. Size of treatment effects and their importance to clinical research and practice. Biol. Psychiatry 2006, 59(11):990-996.
73. The STAR D Investigative Team Sequenced Treatment Alternatives to Relieve Depression (STAR D) Protocol and Analytic Plan (Accessed April 19, 2011). http://www.madinamerica.com/MADINAMERICA.COM/STARD%20Documents_files/STAR-D%20Protocol%20with%20Analytic%20Plan.pdf.
74. Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes. Diabetes Care 2003, 26(9):2518-2523.
75. Laupacis A., Feeny D., Detsky A.S., Tugwell P.X. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ 1992, 146(4):473-481.
76. Guidelines for the Economic Evaluation of Health Technologies 2006, Canadian Agency for Drugs and Technologies in Health, Ottawa, Canada. 3rd ed.
77. Weinstein M.C., Siegel J.E., Gold M.R., Kamlet M.S., Russell L.B. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA 1996, 276(15):1253-1258.
78. ATLAS.ti Version 7.5. [computer software] 2014, Scientific Software Development, Berlin, Germany.
79. Elo S., Kyngas H. The qualitative content analysis process. J. Adv. Nurs. 2008, 62(1):107-115.
80. Patton M.Q. Qualitative research and evaluation methods 2002, Sage Publications, San Francisco.
81. Ma J., Yank V., Xiao L., et al. Translating the diabetes prevention program lifestyle intervention for weight loss into primary care: a randomized trial. JAMA Intern. Med. 2013, 173(2):113-121.
82. Ma J., Berra K., Haskell W.L., et al. Case management to reduce risk of cardiovascular disease in a county health care system. Arch. Intern. Med. 2009, 169(21):1988-1995.
83. Kraemer H.C. To increase power in randomized clinical trials without increasing sample size. Psychopharmacol. Bull. 1991, 27(3):217-224.
84. Harmonised Tripartite Guideline I.C.H. Statistical principles for clinical trials. International Conference on Harmonisation E9 Expert Working Group. Stat. Med. 1999, 18(15):1905-1942.
85. Bender R., Lange S. Adjusting for multiple testing-when and how?. J. Clin. Epidemiol. 2001, 54(4):343-349.
86. Thomas P.R. Weighing the Options: Criteria for Evaluating Weight-Management Programs 1995, Committee to Develop Criteria for Evaluating the Outcomes of Approaches to Prevent and Treat Obesity, Institute of Medicine, Washington, DC.
87. Stevens J., Truesdale K.P., McClain J.E., Cai J. The definition of weight maintenance. Int. J. Obes. (Lond.) 2006, 30(3):391-399.
88. Blaine B.E., Rodman J., Newman J.M. Weight loss treatment and psychological well-being: a review and meta-analysis. J. Health Psychol. 2007, 12(1):66-82.
89. National Institute for Clinical Excellence Depression: Management of Depression in Primary and Secondary Care 2004, National Health Service, London, England.
90. Harris P.A., Taylor R., Thielke R., Payne J., Gonzalez N., Conde J.G. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J. Biomed. Inform. 2009, 42(2):377-381.
91. Conway J.M., Ingwersen L.A., Vinyard B.T., Moshfegh A.J. Effectiveness of the US Department of Agriculture 5-step multiple-pass method in assessing food intake in obese and nonobese women. Am. J. Clin. Nutr. 2003, 77(5):1171-1178.
92. Conway J.M., Ingwersen L.A., Moshfegh A.J. Accuracy of dietary recall using the USDA five-step multiple-pass method in men: an observational validation study. J. Am. Diet. Assoc. 2004, 104(4):595-603.
93. Bellg A.J., Borrelli B., Resnick B., et al. Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH behavior change consortium. Health Psychol. 2004, 23(5):443-451.
94. Miller W.R., Rollnick S. Motivational Interviewing: Preparing People for Change 2002, Guilford Press, New York. 2nd ed.
95. Schneider K.L., Bodenlos J.S., Ma Y., et al. Design and methods for a randomized clinical trial treating comorbid obesity and major depressive disorder. BMC Psychiatry 2008, 8:77.
96. Katon W.J., Von Korff M., Lin E.H., et al. The pathways study: a randomized trial of collaborative care in patients with diabetes and depression. Arch. Gen. Psychiatry 2004, 61(10):1042-1049.
97. Unutzer J., Katon W., Callahan C.M., et al. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA 2002, 288(22):2836-2845.
98. Katon W., Pedersen H.S., Ribe A.R., et al. Effect of depression and diabetes mellitus on the risk for dementia: a national population-based cohort study. JAMA Psychiatry 2015, 72(6):612-619.